IRLAB Therapeutics AB, a company discovering and developing novel treatments for Parkinson’s disease, announced that the company will present an abstract at the International Congress of Parkinson’s Disease and Movement Disorders®, MDS Congress, in Copenhagen, Denmark from August 27-31, 2023.
